These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31340188)

  • 1. Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens.
    D'Cunha R; Schmidt R; Widness JA; Mock DM; Yan X; Cress GA; Kuruvilla D; Veng-Pedersen P; An G
    Eur J Pharm Sci; 2019 Oct; 138():105013. PubMed ID: 31340188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mechanism-Based Population Pharmacokinetics Model of Erythropoietin in Premature Infants and Healthy Adults Following Multiple Intravenous Doses.
    D'Cunha R; Widness JA; Yan X; Schmidt RL; Veng-Pedersen P; An G
    J Clin Pharmacol; 2019 Jun; 59(6):835-846. PubMed ID: 30618050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Juul SE; Massaro AN; Bammler TK; Wu YW
    Pediatr Res; 2017 Jun; 81(6):865-872. PubMed ID: 28099423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher S; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004868. PubMed ID: 16856064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
    Ait-Oudhia S; Scherrmann JM; Krzyzanski W
    J Pharmacol Exp Ther; 2010 Sep; 334(3):897-910. PubMed ID: 20501635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics.
    Chapel SH; Veng-Pedersen P; Schmidt RL; Widness JA
    Exp Hematol; 2001 Apr; 29(4):425-31. PubMed ID: 11301182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidose optimization simulation of erythropoietin treatment in preterm infants.
    Rosebraugh MR; Widness JA; Veng-Pedersen P
    Pediatr Res; 2012 Apr; 71(4 Pt 1):332-7. PubMed ID: 22391632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004868. PubMed ID: 22972077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of recombinant Human erythropoietin in neonatal anemia.
    El-Lahony DM; Saleh NY; Habib MS; Shehata MA; El-Hawy MA
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):147-151. PubMed ID: 31628923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial.
    Brown MS; Keith JF
    Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates.
    Dame C; Langer J; Koller BM; Fauchère JC; Bucher HU
    Neonatology; 2012; 102(3):172-7. PubMed ID: 22776958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm neonates.
    Warwood TL; Ohls RK; Lambert DK; Leve EA; Veng-Pedersen P; Christensen RD
    J Perinatol; 2006 Oct; 26(10):636-9. PubMed ID: 16929342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers.
    Krzyzanski W; Wyska E
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):637-45. PubMed ID: 18071675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects.
    Widness JA; Veng-Pedersen P; Peters C; Pereira LM; Schmidt RL; Lowe LS
    J Appl Physiol (1985); 1996 Jan; 80(1):140-8. PubMed ID: 8847295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Full Target-Mediated Drug Disposition (TMDD) Model to Explain the Changes in Recombinant Human Erythropoietin (rhEpo) Pharmacokinetics in Patients with Different Bone Marrow Integrity Following Hematopoietic Transplantation.
    Wu N; Widness JA; Yan X; Veng-Pedersen P; An G
    J Pharm Sci; 2022 Sep; 111(9):2620-2629. PubMed ID: 35691608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004863. PubMed ID: 24771408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.